Vatorsecurities.se använder sig av cookies för att ge dig som besökare en så bra upplevelse som möjligt.

Analys

Vator Securities uppdragsanalys erbjuds till ett fåtal utvalda life science-bolag – ”By Invitation Only”.

Uppdragsanalyser publiceras löpande under 2019.

Commissioned research: AlzeCure Pharma

AlzeCure Pharma is a Swedish-based pharmaceutical company with potentially first-in-class proprietary and novel targeted small molecule (tablets) candidates for neurodegenerative diseases with a primary target on Alzheimer’s Disease (AD).

AlzeCure’s management team has extensive big pharma experience, and formed an integral part of AstraZeneca’s CNS department.